β-Blocker Dialyzability and Mortality in Older Patients Receiving Hemodialysis
This study does raise caution, but as the authors indicate, causality is different to determine as there was not random allocation of β-Blocker exposure.
PMID:
:
Risk of acute kidney injury associated with the use of fluoroquinolones
Outcomes of In-Hospital Cardiopulmonary Resuscitation in Maintenance Dialysis Patients
Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficileInfection
Source: Nephrology Now - Category: Urology & Nephrology Authors: Nephrology Now editors Tags: Chronic Kidney Disease Clinical Nephrology Hemodialysis Source Type: research
More News: Acebutolol | Atenolol | Bisoprolol | Cardiology | Chronic Kidney Disease | Dialysis | Heart | Hemodialysis | Hospitals | Inderal | Proton Pump Inhibitors PPIs | Study | Toprol | Urology & Nephrology